Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer

NCT06732856 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06732856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06732856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer
Lead sponsor
Asan Medical Center
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 4, 2025
Completion date
December 31, 2027
Enrollment
57 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric (stomach) cancer, stomach neoplasm